Kimia Biosciences Ltd (530313) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 530313 | NSE: | Pharmaceuticals & Drugs | Small Cap

Kimia Biosciences Share Price

29 -0.55 -1.86%
as on 05-Dec'25 12:17

Kimia Biosciences Ltd (530313) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 530313 | NSE: | Pharmaceuticals & Drugs | Small Cap

DeciZen - make an informed investing decision on Kimia Biosciences

Based on:

Overall Rating
Login to view analysis. M-Cap below 500cr. High Risk from low Liquidity Bole Toh

1. Quality


Login to view analysis.

2. Valuation


Login to view analysis.

3. Price Trend


Login to view analysis.

Kimia Biosciences stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
14.55
Market Cap:
139.8 Cr.
52-wk low:
26.1
52-wk high:
86.9

Is Kimia Biosciences Ltd an attractive stock to invest in?


Login to view analysis.

10 Year X-Ray of Kimia Biosciences: Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Kimia Biosciences Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % -216.8%-18.3%11.8%16.9%8.9%16.1%-2.3%-14.3%-4.2%42.2%-
Value Creation
Index
NANA-0.20.2-0.40.2-1.2-2.0-1.32.0-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 0.21.576.393.9106133125129105119119
Sales YoY Gr.-668.4%5,126.7%23.1%13.2%24.9%-5.9%2.9%-18.4%13.4%-
Adj EPS -5.5-1.70.92.70.40.9-0.8-1.6-1.11.92
YoY Gr.-NANA189.4%-85.7%125.6%-194.3%NANANA-
BVPS (₹) -5.3-6.3-0.22.42.93.93.21.20.12.12.5
Adj Net
Profit
-4.1-1.21.441.84.2-3.9-7.6-5.39.210
Cash Flow from Ops. -6-0.7-7.1-2.70.368-6.814.521.3-
Debt/CF from Ops. -1.1-13.2-4.2-11.61107.55.1-7.831.5-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 104.5%2.3%-1.6%13.4%
Adj EPS NA37.8%NANA
BVPSNA-5.9%-12.5%2914.3%
Share Price - -6.8% -14.1% -42%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
220.129-117.594.718.526.2-23.6-74.7-181.4178.789
Op. Profit
Mgn %
-1759.4-56.53.26.14.86.30.5-2.8-0.41711.6
Net Profit
Mgn %
-2122.9-84.51.84.21.73.1-3.1-5.9-57.78.1
Debt to
Equity
-1.7-2.191.27.42.52.42.79.7131.13.31.4
Working Cap
Days
1,99635410217018417920722125021092
Cash Conv.
Cycle
424554584938888907337-9

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials - Kimia Biosciences Ltd.

Standalone Consolidated
TTM EPS (₹) 2 -
TTM Sales (₹ Cr.) 119 -
BVPS (₹.) 2.5 -
Reserves (₹ Cr.) 7 -
P/BV 12.07 -
PE 14.55 -
From the Market
52 Week Low / High (₹) 26.09 / 86.85
All Time Low / High (₹) 0.60 / 86.85
Market Cap (₹ Cr.) 140
Equity (₹ Cr.) 4.7
Face Value (₹) 1
Industry PE 40.7

Management X-Ray of Kimia Biosciences:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Kimia Biosciences - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Kimia Biosciences

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales017694106133125129105119
Operating Expenses 42748810212412413410599
Manufacturing Costs003469101188
Material Costs005971809792967571
Employee Cost 2189111415161514
Other Costs 11455571076
Operating Profit -3-126481-5-020
Operating Profit Margin (%) -1,759.4%-67.2%3.2%5.9%4.2%6.3%0.5%-4.0%-0.5%17.0%
Other Income 0111121121
Interest 1012334455
Depreciation 0011223333
Exceptional Items 0000000-100
Profit Before Tax -4-12416-5-12-714
Tax 0-0-0-0-00-1-3-24
Profit After Tax -4-12415-4-9-510
PAT Margin (%) -2,109.8%-63.7%2.2%4.1%1.3%3.8%-3.0%-7.3%-5.1%8.1%
Adjusted EPS (₹)-5.5-1.31.12.60.31.1-0.8-2.0-1.12.0
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund -4-5041318155010
Share Capital 7722555555
Reserves -11-12-22914101-45
Minority Interest0000000000
Debt792930314139514130
Long Term Debt792524242824312110
Short Term Debt005561315202020
Trade Payables001918273140474050
Others Liabilities 17914151614151319
Total Liabilities 41258658610710911794109

Fixed Assets

Gross Block1271519223444464752
Accumulated Depreciation8023469121619
Net Fixed Assets 371316182835343233
CWIP 0322660110
Investments 0000000000
Inventories011016202437483135
Trade Receivables002929374230312837
Cash Equivalents 0021121011
Others Assets 1121356434
Total Assets 41258658610710911794109

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity -6-1-7-3068-71521
PBT -4-12416-5-12-714
Adjustment 1111446887
Changes in Working Capital -3-0-10-8-5-37-2141
Tax Paid 0-00-000-0000
Cash Flow From Investing Activity -0-6-2-2-9-14-1-3-1-5
Capex -0-6-3-3-9-14-2-3-2-5
Net Investments 00000-01-0-0-0
Others 000000000-0
Cash Flow From Financing Activity 6710488-810-13-17
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing 7311434-37-9-11
Interest Paid -1-0-1-1-1-2-3-3-4-6
Dividend Paid 0000000000
Others 04-0177-25-00
Net Cash Flow 000-000-0-0-00

Finance Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)N/AN/AN/A243.8316.4732.19-22.22-91.91N/A186.7
ROCE (%)N/AN/AN/A16.948.9416.13-2.32-14.3N/A42.18
Asset Turnover Ratio0.040.182.181.521.411.381.161.140.991.17
PAT to CFO Conversion(x)N/AN/A-3.5-0.7501.2N/AN/AN/A2.1
Working Capital Days
Receivable Days34621711141141091058610199
Inventory Days143832450636189121138100
Payable Days2,3912606195101108140165210233

Kimia Biosciences Ltd Stock News

Kimia Biosciences Ltd FAQs

The current trading price of Kimia Biosciences on 05-Dec-2025 12:17 is ₹29.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 04-Dec-2025 the market cap of Kimia Biosciences stood at ₹139.8.
The latest P/E ratio of Kimia Biosciences as of 04-Dec-2025 is 14.55.
The latest P/B ratio of Kimia Biosciences as of 04-Dec-2025 is 12.07.
The 52-week high of Kimia Biosciences is ₹86.85 and the 52-week low is ₹26.09.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Kimia Biosciences is ₹118.9 ( Cr.) .

About Kimia Biosciences Ltd

No data to display
To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×